SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Gilead Sciences Q3 2026 Earnings Call Begins

Gilead Sciences' Q3 2026 earnings call has begun.

GILD
SquawkNews Desk

Gilead Sciences's quarterly earnings call has just begun.Live earnings calls are not yet supported in the mobile app. To listen and follow along in real time, open TradingView website in your browser.

Related stories

X2M Connect Reports Q1 FY27 Revenue of A$1.4 Million X2M Connect posted revenue of A$1.4 million for Q1 FY27. M impact | EQUITY | Oct 30, 2026, 01:20 AM UTC OncoSil Medical Q1 FY27 Sales Revenue Rises 45.8% Year On Year M impact | EQUITY | Oct 30, 2026, 01:20 AM UTC Xreality Group Posts Quarterly Annual Recurring Revenue of A$8.8 Million M impact | EQUITY | Oct 30, 2026, 01:20 AM UTC Hiremii Posts Q1 FY27 Revenue of A$7.056 Million M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC Reece Reports Q1 FY27 Sales Revenue of A$2,510 Million M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC Reece Reports Q1 FY27 Sales Revenue of A$2.510 Billion M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC